Company Cyber Security Posture
NANA
NA Company Details
NA
NA
NA
NA
NA
NA
Scan still pending
NA
NA

Between 200 and 800
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.

.png)

Company Scoring based on AI Models
Model Name | Date | Description | Current Score Difference | Score |
---|---|---|---|---|
AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 200 and 800 |
Company Cyber Security News & History
Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
---|
Company Subsidiaries

NA
Access Data Using Our API

Get company history
.png)
NA Cyber Security News
Gene Editing: CRISPR Therapeutics vs. Beam Therapeutics
CRISPR Therapeutics is a safer bet due to products getting close to commercialization, good preliminary clinical trial results, and a larger cash balance.
Beam Therapeutics (BEAM) Up 5.7% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Beam Therapeutics Inc. (BEAM). Shares have added about 5.7% in that time frame,ย ...
Is Beam Therapeutics Inc. (BEAM) the Best Gene-Editing Stock to Buy?
In this article, we are going to take a look at where Beam Therapeutics Inc. (NASDAQ:BEAM) stands against other best gene-editing stocks to buy.
7 Top Gene-Editing Stocks to Buy | Investing
7 Top Gene-Editing Stocks to Buy ยท Eli Lilly & Co. (LLY) ยท Sanofi (SNY) ยท Vertex Pharmaceuticals Inc. (VRTX) ยท CRISPR Therapeutics AG (CRSP).
Top 5 CRISPR Companies To Invest In (June 2025)
Discover what CRISPR is, and the companies innovating within this rapidly-growing, high-potential field of scienec.
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precisionย ...
Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precisionย ...
Beam Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
First Patient Dosed in the Phase 1/2 Study of BEAM-301 in Glycogen Storage Disease Type Ia, Beam's Second Clinical Stage In Vivo Editingย ...
FDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)โ AATD Gene Therapy
Beam Therapeutics Inc. (NASDAQ:BEAM) has secured U.S. FDA orphan drug designation for BEAM-302, its pioneering genetic medicine targetingย ...

NA Similar Companies

ICON plc
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality

The National Institutes of Health
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an

CSL
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by ou

Avantor
Avantorยฎ is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

Agilent Technologies
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product

Jabatan Pertanian Malaysia
Jabatan Pertanian adalah salah sebuah agensi di bawah Kementerian Pertanian dan Industri Asas Tani. Core Bussiness bagi Jabatan Pertanian adalah Aktiviti Pengembangan kepada petani dan usahawan tani. Ibu Pejabat Jabatan Pertanian terletak di Prsint 4, Wisma Tani, Putrajaya dan juga terdapat Pejabat

Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
NA CyberSecurity History Information
How many cyber incidents has NA faced?
Total Incidents: According to Rankiteo, NA has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at NA?
Incident Types: The types of cybersecurity incidents that have occurred include .
Additional Questions
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
